These data strongly suggest that CDK1, CDK4, CHEK1, and G6PD are potential prognostic biomarkers in HCC and key therapeutic targets for EZW to suppress HCC based on the cellular senescence process. This evidence concerns the gene G6PD and hepatocellular carcinoma.